Amundi’s BioLife Solutions BLFS Stock Holding History

Amundi’s Portfolio BLFS Stock Details BLFS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-3,785	Closed	-$89K	–	1907
2022 Q3	$89K	Hold	3,785	–	–	﹤0.01%	1579
2022 Q2	$59K	Hold	3,785	–	–	﹤0.01%	1525
2022 Q1	$83K	Hold	3,785	–	–	﹤0.01%	1495
2021 Q4	$116K	Buy	+3,785	New	+$162K	﹤0.01%	1551

Other funds holding BLFS

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Amundi's BLFS Position: Q4 2022 in Review

Amundi sold out of BioLife Solutions (BLFS) in Q4 2022, closing a stake of 3,785 shares — an estimated $89K sold.

Amundi first reported a position in BLFS in Q4 2021 and held it in 4 quarters. The position peaked at $116K in Q4 2021. 165 funds tracked by Wall St. Rank hold BLFS as of Q4 2022.

Amundi reported no remaining BioLife Solutions position as of Q4 2022 after selling out during the quarter.
Amundi sold 3,785 BioLife Solutions shares in Q4 2022, an estimated $89K.
Amundi first reported a position in BioLife Solutions in Q4 2021 and held it in 4 quarters.
Amundi's BioLife Solutions position peaked at $116K in Q4 2021.
165 funds tracked by Wall St. Rank held BioLife Solutions as of Q4 2022.

Based on Amundi's 13F filing for Q4 2022, filed 14 Feb 2023.